Zobrazeno 1 - 10
of 22
pro vyhledávání: '"P. M. Bet"'
Autor:
F. Linsen, C. Broeder, M. S. C. Sep, J. E. Verhoeven, P. M. Bet, B. W. J. H. Penninx, O. C. Meijer, C. H. Vinkers
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Major depressive disorder (MDD) is a heterogeneous psychiatric disorder. Childhood trauma (CT, emotional/physical/sexual abuse or neglect before the age of 18) is one of the largest and most consistent risk factors for development
Externí odkaz:
https://doaj.org/article/392365ce87254f0ba560ee373f329931
Autor:
R. van Westrhenen, R. H. N. van Schaik, T. van Gelder, T. K. Birkenhager, P. R. Bakker, E. J. F. Houwink, P. M. Bet, W. J. G. Hoogendijk, M. J. M. van Weelden-Hulshof
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Effective pharmacologic treatments for psychiatric disorders are available, but their effect is limited due to patients’ genetic heterogeneity and low compliance-related to frequent adverse events. Only one third of patients respond to treatment an
Externí odkaz:
https://doaj.org/article/7598e28a637d4ebd86252e89be015fee
Autor:
Jurriaan M. J. L. Brouwer, Klaas J. Wardenaar, Ilja M. Nolte, Edith J. Liemburg, Pierre M. Bet, Harold Snieder, Hans Mulder, Danielle C. Cath, Brenda W. J. H. Penninx
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Tailoring antidepressant drugs (AD) to patients’ genetic drug-metabolism profile is promising. However, literature regarding associations of ADs’ treatment effect and/or side effects with drug metabolizing genes CYP2D6 and CYP
Externí odkaz:
https://doaj.org/article/61fa815c9a504b8985aa02bad90433c4
Autor:
Agnes van Minnen, Lizelotte Vos, Pierre M. Bet, Ad de Jongh, Felix Linsen, Hein J. F. van Marle, Onno C. Meijer, Willem M. Otte, Marije Russcher, Christiaan H. Vinkers
Publikováno v:
Case Reports in Psychiatry, Vol 2024 (2024)
Despite the availability of various treatment approaches for patients with posttraumatic stress disorder (PTSD), some patients do not respond to these therapies, and novel treatment approaches are needed. This study investigated the efficacy of mifep
Externí odkaz:
https://doaj.org/article/8c8392000c1d4da7902ea8fa4857941e
Autor:
Leila Atmowihardjo, Job R. Schippers, Imke H. Bartelink, Pierre M. Bet, Nienke van Rein, Keith Purdy, David Cavalla, Valérie Comberiati, Andrew McElroy, Sue D. Snape, Harm Jan Bogaard, Leo Heunks, Nicole Juffermans, Marcus Schultz, Pieter R. Tuinman, Lieuwe D. J. Bos, Jurjan Aman
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-17 (2022)
Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has led to a disruptive increase in the number of intensive care unit (ICU) admissions with acute respiratory distress syndrome (ARDS). ARDS is a severe, life-threatening medical co
Externí odkaz:
https://doaj.org/article/27dbdb47d79d4a0092fff3b3856e4135
Autor:
Imke H. Bartelink, Pierre M. Bet, Nicolas Widmer, Monia Guidi, Erik Duijvelaar, Bram Grob, Richard Honeywell, Amanda Evelo, Ivo P. E. Tielbeek, Sue D. Snape, Henrike Hamer, Laurent A. Decosterd, Harm Jan Bogaard, Jurjan Aman, Eleonora L. Swart
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 12, Pp 1497-1511 (2021)
Abstract This study aimed to determine whether published pharmacokinetic (PK) models can adequately predict the PK profile of imatinib in a new indication, such as coronavirus disease 2019 (COVID‐19). Total (bound + unbound) and unbound imatinib pl
Externí odkaz:
https://doaj.org/article/84259887a4a245ea94b698c03f036179
Autor:
Marieke J. Henstra, Thomas C. Feenstra, Rob M. Kok, Harm-Pieter Spaans, Eric van Exel, Annemiek Dols, Mardien Oudega, Anton C. M. Vergouwen, Adriano van der Loo, Pierre M. Bet, Stephan A. Loer, Merijn Eikelenboom, Pascal Sienaert, Simon Lambrichts, Filip Bouckaert, Judith E. Bosmans, Nathalie van der Velde, Aartjan T. F. Beekman, Max L. Stek, Didi Rhebergen
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
BackgroundCognitive side-effects are an important reason for the limited use of electroconvulsive therapy (ECT). Cognitive side-effects are heterogeneous and occur frequently in older persons. To date, insight into these side-effects is hampered due
Externí odkaz:
https://doaj.org/article/05849dcdd85d453c8fbb5959a0a507e3
Autor:
Forike K. Martens, Daan W. Huntjens, Tessel Rigter, Meike Bartels, Pierre M. Bet, Martina C. Cornel
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2020)
IntroductionThe fluoropyrimidines (FP) (5-Fluorouracil, capecitabine, and tegafur) are commonly used anti-cancer drugs, but lead to moderate to severe toxicity in about 10–40% of patients. DPD testing [either the enzyme activity of dihydropyrimidin
Externí odkaz:
https://doaj.org/article/954d40ebde3747c0a1475b19c50197ff
Publikováno v:
European Journal of Hospital Pharmacy. European Association of Hospital Pharmacists (EAHP)
Leeuwerik, A F, van Merendonk, L N, de Boer, M A, Wilhelm, A J, Kolkman, A & Bet, P M 2023, ' A new approach to drug intravenous compatibility research : The case of obstetric parenteral drugs ', European Journal of Hospital Pharmacy . https://doi.org/10.1136/ejhpharm-2022-003577
Leeuwerik, A F, van Merendonk, L N, de Boer, M A, Wilhelm, A J, Kolkman, A & Bet, P M 2023, ' A new approach to drug intravenous compatibility research : The case of obstetric parenteral drugs ', European Journal of Hospital Pharmacy . https://doi.org/10.1136/ejhpharm-2022-003577
Objectives: The product information and literature does not provide confirmation of compatibility for co-administration of all commonly used drug pairs in obstetrics. However, there is a need for co-administration of these drugs over one lumen for th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5600783a585c7f3022de59bfdb4f2133
https://research.vumc.nl/en/publications/26e92c26-3659-4100-8491-95ab3ee8e8a5
https://research.vumc.nl/en/publications/26e92c26-3659-4100-8491-95ab3ee8e8a5
Autor:
Eric W. de Heer, Jack Dekker, Aartjan T. F. Beekman, Harm W. J. van Marwijk, Tjalling J. Holwerda, Pierre M. Bet, Joost Roth, Lotte Timmerman, Christina M. van der Feltz-Cornelis
Publikováno v:
Frontiers in Psychiatry, Vol 9 (2018)
ObjectiveEvidence exists for the efficacy of collaborative care (CC) for major depressive disorder (MDD), for the efficacy of the consequent use of pain medication against pain, and for the efficacy of duloxetine against both MDD and neuropathic pain
Externí odkaz:
https://doaj.org/article/45e26eba82df4f498cfcfef49c090d60